检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.
研究兴趣

论文共 534 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Abstract 5986: Significance of LIF/LIFR axis in the progression of inflammatory breast cancer
Bianca Romo, Zenaida Fuentes,Lois Randolph,Bindu Santhamma,Hareesh Nair, Christoforos Thomas,Ratna Vadlamudi,Suryavathi Viswanadhapalli
Cancer Researchno. 6_Supplement (2024): 5986-5986
引用0浏览0引用
0
0
Abstract 2100: Novel LIPA targeted therapy for treating inflammatory breast cancer
Zenaida Fuentes,Rahul Gopalam, Bianca A. Romo, Khaled Mohamed Nassar,Xue Yang,Behnam Ebrahimi, Paulina Ramirez, Chia-Yuan Chen, Scott Elmore, Harika Nagandla,Uday Pratap, Christoforos Thomas,
Cancer Researchno. 6_Supplement (2024): 2100-2100
引用0浏览0引用
0
0
Abstract 5892: SCUBE3 promotes therapy resistance in triple negative breast cancer
Deepika Singh, Daisy Medina,Benjamin Onyeagucha, Rahul Mojidra, Panneerdoss Subbarayallu, Alex Taylor, Dongwen Lyu,Santosh Timilsina, Prabhakar Pitta Venkata, Saif S R Nirzhor, Shahad M. Abdulsahib, Trong Phat Do,
Cancer Researchno. 6_Supplement (2024): 5892-5892
引用0浏览0引用
0
0
Abstract 3172: Significance of PELP1 signaling in liver cancer progression
Uday Pratap, Khaled Mohamed Nassar, Xue Yang, Adriana Baker,Rahul Gopalam, William C. Arnold, Timilehin Adeniran, Marian Helena Hernandez Fernandez,Gangadhara R. Sareddy,Suryavathi Viswanadhapalli,Luzhe Sun,Ratna K. Vadlamudi
Cancer Researchno. 6_Supplement (2024): 3172-3172
引用0浏览0引用
0
0
Abstract 628: RNA binding protein Matrin3 acts as a tumor suppressor by inhibiting microtubule nucleation
Panneerdoss Subbarayalu,Subapriya Rajamanickam,Santosh Timilsina, Saif Nirzhor, Daisy Medina, Shahad Abdulsahib, Pitta V Prabhakar, Deepika Singh,Fu-Yang Li,Pooja Yadav, Esha Reddy, Krishna Evani,
Cancer Researchno. 6_Supplement (2024): 628-628
引用0浏览0引用
0
0
加载更多
作者统计
  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn